Healthcare (Feb 2023)

Medication Adherence of People Living with HIV in Japan—A Cross-Sectional Study

  • Yoji Inoue,
  • Shinichi Oka,
  • Seiji Yokoyama,
  • Koichi Hasegawa,
  • Jörg Mahlich,
  • Ulrike Schaede,
  • Noriyuki Habuka,
  • Yoko Murata

DOI
https://doi.org/10.3390/healthcare11040451
Journal volume & issue
Vol. 11, no. 4
p. 451

Abstract

Read online

Long-term medical care for people living with HIV (PLHIV) is critical for treatment efficacy, and various studies have examined reasons for antiretroviral therapy (ART) non-adherence. In Japan, doctors assume patients maintain high adherence. However, little is known about real-world treatment adherence. We conducted an anonymous self-administered web-based survey asking about adherence for a total of 1030 Japanese PLHIV who were currently on ART. Adherence was determined using the eight-item Morisky Medication Adherence Scale (MMAS-8), for which scoring ranged from 0 to 8 and scores p p = 0.001), moderate to severe depression (p = 0.002, using the PHQ-9), and drug dependence (p = 0.043). Adherence was also influenced by a shared decision-making process, including treatment selection, doctor–patient relations, and treatment satisfaction. Adherence was mainly affected by treatment decision factors. Hence, support of care providers should be considered critical for improving adherence.

Keywords